Literature DB >> 15483418

Partial liquid ventilation with FC-77 suppresses the release of lipid mediators in rat acute lung injury model.

Yoh Hirayama1, Hiroyuki Hirasawa, Shigeto Oda, Hidetoshi Shiga, Kenichi Matsuda, Hirokazu Ueno, Masataka Nakamura.   

Abstract

OBJECTIVE: To investigate whether the release of lipid mediators is suppressed in rats with experimentally induced acute lung injury managed with partial liquid ventilation (PLV) using FC-77.
DESIGN: Prospective, randomized controlled study.
SETTING: Research laboratory in a university.
SUBJECTS: Male Sprague-Dawley rats.
INTERVENTIONS: After tracheostomy was performed under general anesthesia, lung injury was induced by intratracheal instillation of HCl. The PLV group was then subjected to conventional gas ventilation for 30 mins, followed by PLV using FC-77. The control group was subjected to conventional gas ventilation throughout the study period.
MEASUREMENTS AND MAIN RESULTS: In the PLV group the following results were obtained: a) impaired oxygenation was markedly improved; b) the increase in the serum levels of lipid mediators such as leukotriene B4, thromboxane A2, and 6-keto-prostaglandin F1alpha was suppressed; and c) the increase in the concentrations of leukotriene B4, thromboxane A2, and 6-keto-prostaglandin F1alpha in the total lung homogenate at 180 mins after lung injury was also suppressed.
CONCLUSION: This study indicates that PLV using FC-77 suppresses the release of lipid mediators in our rat model of acute lung injury. However, further investigation is needed to clarify the precise mechanism of this effect.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15483418     DOI: 10.1097/01.ccm.0000142576.59654.bc

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  3 in total

1.  In vivo MRI virtual colonography in a mouse model of colon cancer.

Authors:  Lilia V Ileva; Marcelino Bernardo; Matthew R Young; Lisa A Riffle; James L Tatum; Joseph D Kalen; Peter L Choyke
Journal:  Nat Protoc       Date:  2014-10-23       Impact factor: 13.491

2.  Effects of Emulsion Composition on Pulmonary Tobramycin Delivery During Antibacterial Perfluorocarbon Ventilation.

Authors:  Ryan A Orizondo; Mario L Fabiilli; Marissa A Morales; Keith E Cook
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2016-01-07       Impact factor: 2.849

3.  Characterization of a reverse-phase perfluorocarbon emulsion for the pulmonary delivery of tobramycin.

Authors:  Ryan A Orizondo; Charlene Irvin Babcock; Mario L Fabiilli; Leonid Pavlovsky; J Brian Fowlkes; John G Younger; Keith E Cook
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2014-01-29       Impact factor: 2.849

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.